Filament Health issues new Canadian patent for natural psilocybin estate
Rhelion Life Sciences says its wholly owned subsidiary Filament Health issued a new Canadian patent extending its natural psilocybin patent estate.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.